About Vyaire
Vyaire is a Healthcare company based in Illinois City (United States) founded in 2016, and was acquired by Apax in March 2018. Respiratory devices for diagnostics, ventilation, and patient monitoring are developed. Vyaire has raised $31.53 million across 1 funding round from investors including Apax Partners. The company has 34 employees. Vyaire has completed 4 acquisitions, including Acutronic Medical, Ciel Medical Devices and MIM Germany. Its chief executive, as recorded, is Gaurav Agarwal. Its Indian entity Vyaire Medical Private Limited reported revenue of ₹7.62 Cr. Vyaire offers products and services including Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its competitors include Third Pole Therapeutics, Spry Therapeutics and Ventec Life Systems; 2 of its 3 listed competitors have raised funding.
Company details
Vyaire Medical was formed in 2016 via a joint venture between BD and Apax Partners, based in Illinois City, United States. Operations center on the medical devices sector, with emphasis on respiratory care. Devices for spirometry, pulmonary function testing, metabolic analysis, sleep diagnostics, ventilation support, anesthesia delivery, and patient monitoringincluding ECG, blood pressure, and temperature systemsare produced and supplied to healthcare providers globally.
- Headquarters Illinois City, United States
- Employees 34
- Stage Acquired
- SectorsHealthcare
- Website vyaire.com
- Social LinkedIn X Facebook Instagram
- Acquired by Apax (Mar 2018)
- Legal Name Vyaire Medical Private Limited
- Date of Incorporation 09 Sep, 2016
- Jurisdiction Noida, Uttar Pradesh, India
- Indian entity revenue₹7.62 Cr
FY 2025 · -42% YoY
- Indian entity net loss-₹4.19 Cr
FY 2025 · -55% margin
- Indian entity EBITDA-₹4.15 Cr
FY 2025 · -54% margin
- Total Equity Funding$31.53M (USD)
in 1 rounds
- Latest Funding Round$31.53M (USD), Series B
Jan 2019
- Investors
- Employee Count34
- Investments & AcquisitionsAcutronic Medical
& 3 more
- Acquired byApax
(Mar 2018)
Associated legal entities of Vyaire
Vyaire operates through Vyaire Medical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vyaire Medical Private Limited CIN U29304UP2016FTC140139 | Active | 09 Sep 2016 | Noida, Uttar Pradesh | ₹7.6 Cr | 34 | 3 | View details |
Products & Services of Vyaire
Vyaire offers a comprehensive portfolio of products and services, including Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS.
System for body plethysmography in respiratory diagnostics.
Device for pulmonary and cardiopulmonary stress testing.
Ventilation support for patient respiratory needs.
Portable ventilators for long-term and transport care.
Comprehensive system for neonatal through adult ventilation.
Funding Insights of Vyaire
Vyaire has successfully raised a total of $31.53M through 1 strategic funding round. The most recent funding activity was a Series B round of $31.53 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.53M
- Total Rounds 1
- Last Round Series B — $31.53M
- First Round $31.53M
(Jan 2019)
All 1 funding rounds of Vyaire with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $31.53M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in Vyaire
Vyaire has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Apax Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Equity investments are focused on tech, services, and consumer sectors. | 1981 | apax.com | Hong Kong, China |
Investor details for Vyaire
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vyaire Medical Private Limited (Vyaire)
Vyaire Medical Private Limited is the primary company behind Vyaire. The board of Vyaire Medical Private Limited currently have 3 directors; the longest-serving is Rachel Sauer Lisenby, appointed in 2024. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rachel Sauer Lisenby DIN 10453325 | Additional Director | 30 Jan 2024 | 2 yrs 9 mo | Vyaire Medical Private Limited |
| Kunneparambil Hamsa Ayoobkhan DIN 10276557 | Director | 06 Mar 2025 | 1 yr 7 mo | Vyaire Medical Private Limited |
| Abhishek Mishra DIN 05113215 | Director | 31 May 2025 | 1 yr 5 mo | Vyaire Medical Private Limited |
People of Vyaire
1 people are tracked at Vyaire (1 in leadership); the tracked headcount is 34.
| Name | Role | Group |
|---|---|---|
Gaurav Agarwal | CEO | Leadership |
Complete people profiles for Vyaire
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vyaire
Figures of Vyaire Medical Private Limited, the primary company behind Vyaire, for FY 2025. Revenue was ₹7.62 Cr (-42% year on year). Net loss was -₹4.19 Cr (-55% margin). EBITDA was -₹4.15 Cr (-54% margin). Revenue has grown at a compounded annual rate of -11% over three years and +1% over five years.
- ₹7.62 CrRevenue · FY 2025 · -42% YoY
- -₹4.19 CrNet loss · -55% margin
- -₹4.15 CrEBITDA · -54% margin
- ₹3.52 CrPaid-up capital
- 34Employees (provident fund records)
- -11%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vyaire Medical Private Limited are on its company page.
Detailed financial statements for Vyaire
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vyaire
Vyaire has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Acutronic Medical, Ciel Medical Devices and MIM Germany.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medical ventilation systems are manufactured for healthcare applications in Germany. | mim-germany.com | Hamburg, Germany | 1975 | May 2018 | •••• | |
Non-invasive ventilation devices are developed for ENT and thoracic surgery. | acutronic-medical.ch | Hirzel, Switzerland | 1981 | Apr 2018 | •••• | |
Airway management products are developed for medical applications. | rmdevices.com | Tucson, United States | 2013 | Oct 2017 | •••• | |
Specialized devices are developed to prevent ventilator-associated pneumonia in hospitals. | cielmedical.com | San Carlos, United States | 2012 | Apr 2017 | •••• |
Complete acquisition details for Vyaire
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Vyaire
7 dated milestones of Vyaire across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Vyaire is founded.
- Acquisition Acquires Ciel Medical Devices.
- Acquisition Acquires Revolutionary Medical Devices.
- Exit Acquired by Apax.
- Acquisition Acquires Acutronic Medical.
- Acquisition Acquires MIM Germany.
- Funding First funding round of $31.5M.
Competitors of Vyaire
Vyaire has 3 listed competitors in our database, 2 of them funded. They include Third Pole Therapeutics, Spry Therapeutics and Ventec Life Systems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pole3.com | 2014 | Boston, United States | $87.6M | Developer of devices for cardiopulmonary therapies | ||
| sprytherapeutics.com | 2018 | White Plains, United States | Provides innovative health pillows and technologies for infection prevention and comfort. | |||
| venteclife.com | 2013 | Bothell, United States | $60.59M | 103 | Respiratory devices for ICU settings are developed and manufactured. |
Detailed competitors of Vyaire
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vyaire
The website of Vyaire (vyaire.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▼ 37.5% vs previous month
Websites whose visitors overlap most with Vyaire. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| relinkonline.com | 100% | #966,035 | View details | ||
outfrontmedical.com | outfrontmedical.com | 95% | #3,970,655 | – | |
| avantehs.com | 91% | 38.2K | #838,638 | View details | |
| duomed.com | 88% | 52.1K | #630,859 | View details | |
| usme.com | 87% | 11.9K | #1,829,566 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Vyaire
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as Vyaire (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vyaire
Complete news archive for Vyaire
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vyaire
Vyaire was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Vyaire is headquartered in Illinois City, United States. It is registered at Illinois City, Illinois, United States.
Gaurav Agarwal is the CEO of Vyaire, as recorded in our data.
Vyaire is a funded company, having raised a total of $31.53M across 1 funding round to date. The company's 1st funding round was a Series B of $31.53M, raised on Jan 2019.
Vyaire has 34 employees.
The primary company behind Vyaire, Vyaire Medical Private Limited, reported revenue of ₹7.62 Cr for FY 2025, down 42% year on year.
Vyaire Medical was formed in 2016 via a joint venture between BD and Apax Partners, based in Illinois City, United States. Operations center on the medical devices sector, with emphasis on respiratory care. Devices for spirometry, pulmonary function testing, metabolic analysis, sleep diagnostics, ventilation support, anesthesia delivery, and patient monitoringincluding ECG, blood pressure, and temperature systemsare produced and supplied to healthcare providers globally.
Vyaire's top competitors include Third Pole Therapeutics, Ventec Life Systems and Spry Therapeutics.
Vyaire offers Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS.
Vyaire has made 4 acquisitions, including Acutronic Medical, Ciel Medical Devices, and MIM Germany.
Vyaire has 1 investor. Key investors include Apax Partners.
Vyaire operates through Vyaire Medical Private Limited.